Skip to content

Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children

Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02421952
Acronym
BARF
Enrollment
208
Registered
2015-04-21
Start date
2013-04-30
Completion date
2018-09-07
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Nausea and Vomiting

Brief summary

Pediatric research in the management of nausea has been limited by the absence of a reliable method to quantify the intensity of this subjective symptom. In adults, the visual analog scale (VAS) is an accurate tool, but this has not been shown to be reliable in young children. By default the most common objective outcome measure used in pediatric studies has been the incidence and number of emetic episodes. This measure, however, correlates poorly with the somatic subjective symptom of nausea.

Detailed description

Pediatric research in the management of nausea has been limited by the absence of a reliable method to quantify the intensity of this subjective symptom. In adults, the visual analog scale (VAS) is an accurate tool, but this has not been shown to be reliable in young children. By default the most common objective outcome measure used in pediatric studies has been the incidence and number of emetic episodes. This measure, however, correlates poorly with the somatic subjective symptom of nausea. Apfel et al have shown that 30-40% of adult patients undergoing surgery have post discharge nausea and / or vomiting while 12% have vomiting. These data on nausea in adults were based on a visual analog scale for nausea. There are no data on the incidence of postoperative nausea in children since the severity of symptoms are difficult to measure as younger children are known to be unable to use the VAS reliably. Recently a pictorial scale for measuring nausea, the Baxter Animated Retching Faces (BARF) scale, has been developed and shown to have construct, content and convergent validity as an instrument to measure nausea in children. The clinical usefulness of this scale in determining the incidence of postoperative and post-discharge nausea in children has yet to be determined including the lowest age where it can be used reliably, the score associated with a patient's perception of a need for treatment, the minimum change in the scores of clinical relevance and the test-retest reliability when nausea is rated as not having changed.

Interventions

None listed

Sponsors

Baylor College of Medicine
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
3 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age \> 3 years but below 18 years 2. Elective surgery 3. American Society of Anesthesiologists physical status 1-3 (Free from major concurrent disorders) 4. Free from nausea and / or vomiting in the previous 24 hours 5. Cognitive, visual, hearing and communicative ability to use the VAS as shown by the ability to complete a seriation task in which children pick the biggest of 6 cut out shapes, then the smallest, and the biggest remaining until no shapes remain (Beyer et al: J Pediatr Nurs 1992; 7: 335-46)

Exclusion criteria

1. Developmental delay 2. Blindness 3. Impaired cognitive or communicative abilities including inability to rate the intensity of symptoms and failure to complete the seriation task 4. Surgical procedures which may result in diminished hearing or vision in the immediate postoperative period 5. Nausea and /or vomiting within 24 hours prior to the procedure 6. Inability to understand English, 7. Patient or parental refusal to participate 8. Pregnant females

Design outcomes

Primary

MeasureTime frameDescription
Number of Patients With Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in the Post-Anesthetic Care Unit (PACU)When awake and responding to commands in the post-anesthesia care unit (PACU)To measure pain and nausea, subjects completed the VAS and two pictorial scales (Faces Pain Scale-Revised for pain and BARF for nausea). The VAS uses a horizontal 10cm line with the extremes of no pain at all and worst pain imaginable. The subject marks on the line their pain rating. Higher points indicate more severe or intense pain. FACES scale has 6 faces with assigned scores ranging from 0 to 10 with a score difference of 2 between each face (a higher score indicates more pain). The BARF scales has 6 faces with assigned scores ranging from 0 to 10 with a score difference of 2 between each face (a higher score indicates more nausea).

Secondary

MeasureTime frameDescription
Incidence of Post-Discharge Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in Subjects Who Returned the DiaryFirst 24 postoperative hoursPatients were discharged from the PACU when they achieved institutional discharge criteria. The parents were given a diary to record the maximum nausea on the VAS and BARF scales during the first 24 postoperative hours. Each child's caretaker was contacted by phone 24 hours after surgery to determine whether the child had any nausea or vomiting and which medications were given after discharge. The VAS uses a horizontal 10cm line with the extremes of no pain at all and worst pain imaginable. The subject marks on the line their pain rating. Higher points indicate more severe or intense pain. FACES scale has 6 faces with assigned scores ranging from 0 to 10 with a score difference of 2 between each face (a higher score indicates more pain). The BARF scales has 6 faces with assigned scores ranging from 0 to 10 with a score difference of 2 between each face (a higher score indicates more nausea).
Age-Related Ability to Use the BARF ScaleComprehensiveThe age-related ability to use the BARF scale was determined by constructing receiver operating characteristic (ROC) curves and calculating the area under the ROC curve and the 95% confidence interval (CI), along with sensitivity and specificity.

Countries

United States

Participant flow

Participants by arm

ArmCount
Single Cohort
All subjects will be asked to assess their pain and nausea using the visual analogue scales (VAS), the modified faces scale and the BARF scale as described below in the preoperative and postoperative areas.
208
Total208

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDiary Not Returned93
Overall StudyFailed seriation task13
Overall StudySubject uncooperative for baseline test2
Overall StudySurgery cancelled1

Baseline characteristics

CharacteristicSingle Cohort
Age, Customized
12-17.9 years
22 Participants
Age, Customized
3-3.9 years
32 Participants
Age, Customized
4-4.9 years
18 Participants
Age, Customized
5-5.9 years
26 Participants
Age, Customized
6-6.9 years
18 Participants
Age, Customized
7-7.9 years
21 Participants
Age, Customized
8-11.9 years
71 Participants
Could use BARF for all time points190 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
208 participants
Sex/Gender, Customized
Female
67 Participants
Sex/Gender, Customized
Male
124 Participants
Sex/Gender, Customized
Unknown
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 208
other
Total, other adverse events
0 / 208
serious
Total, serious adverse events
0 / 208

Outcome results

Primary

Number of Patients With Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in the Post-Anesthetic Care Unit (PACU)

To measure pain and nausea, subjects completed the VAS and two pictorial scales (Faces Pain Scale-Revised for pain and BARF for nausea). The VAS uses a horizontal 10cm line with the extremes of no pain at all and worst pain imaginable. The subject marks on the line their pain rating. Higher points indicate more severe or intense pain. FACES scale has 6 faces with assigned scores ranging from 0 to 10 with a score difference of 2 between each face (a higher score indicates more pain). The BARF scales has 6 faces with assigned scores ranging from 0 to 10 with a score difference of 2 between each face (a higher score indicates more nausea).

Time frame: When awake and responding to commands in the post-anesthesia care unit (PACU)

Population: Patients with severe nausea were included in the number with any nausea. Patients with severe emesis were included in the number with any emesis. Because some patients had both nausea and vomiting, the sum of the number with nausea and the number with emesis will not equal those with either nausea or emesis.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Single CohortNumber of Patients With Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in the Post-Anesthetic Care Unit (PACU)Postoperative Nausea OR Vomiting62 Participants
Single CohortNumber of Patients With Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in the Post-Anesthetic Care Unit (PACU)Any Nausea60 Participants
Single CohortNumber of Patients With Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in the Post-Anesthetic Care Unit (PACU)Severe Nausea (Score >6)13 Participants
Single CohortNumber of Patients With Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in the Post-Anesthetic Care Unit (PACU)Any Emesis8 Participants
Single CohortNumber of Patients With Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in the Post-Anesthetic Care Unit (PACU)Severe Emesis (>= 3 episodes)2 Participants
Single CohortNumber of Patients With Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in the Post-Anesthetic Care Unit (PACU)Rescue Antiemetics16 Participants
Single CohortNumber of Patients With Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in the Post-Anesthetic Care Unit (PACU)Postoperative Nausea AND Vomiting6 Participants
Secondary

Age-Related Ability to Use the BARF Scale

The age-related ability to use the BARF scale was determined by constructing receiver operating characteristic (ROC) curves and calculating the area under the ROC curve and the 95% confidence interval (CI), along with sensitivity and specificity.

Time frame: Comprehensive

Population: All enrolled subjects were included.

ArmMeasureGroupValue (NUMBER)
Single CohortAge-Related Ability to Use the BARF Scale5-5.9 years81.1 percentage
Single CohortAge-Related Ability to Use the BARF Scale7-7.9 years59.5 percentage
Single CohortAge-Related Ability to Use the BARF Scale4-4.9 years89.5 percentage
Single CohortAge-Related Ability to Use the BARF Scale8-11.9 years48.4 percentage
Single CohortAge-Related Ability to Use the BARF Scale6-6.9 years68.9 percentage
Single CohortAge-Related Ability to Use the BARF Scale12-17.9 years11.6 percentage
Single CohortAge-Related Ability to Use the BARF Scale3-3.9 years100 percentage
SpecificityAge-Related Ability to Use the BARF Scale12-17.9 years100 percentage
SpecificityAge-Related Ability to Use the BARF Scale3-3.9 years0 percentage
SpecificityAge-Related Ability to Use the BARF Scale4-4.9 years70.6 percentage
SpecificityAge-Related Ability to Use the BARF Scale5-5.9 years82.4 percentage
SpecificityAge-Related Ability to Use the BARF Scale6-6.9 years100 percentage
SpecificityAge-Related Ability to Use the BARF Scale7-7.9 years100 percentage
SpecificityAge-Related Ability to Use the BARF Scale8-11.9 years100 percentage
Secondary

Incidence of Post-Discharge Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in Subjects Who Returned the Diary

Patients were discharged from the PACU when they achieved institutional discharge criteria. The parents were given a diary to record the maximum nausea on the VAS and BARF scales during the first 24 postoperative hours. Each child's caretaker was contacted by phone 24 hours after surgery to determine whether the child had any nausea or vomiting and which medications were given after discharge. The VAS uses a horizontal 10cm line with the extremes of no pain at all and worst pain imaginable. The subject marks on the line their pain rating. Higher points indicate more severe or intense pain. FACES scale has 6 faces with assigned scores ranging from 0 to 10 with a score difference of 2 between each face (a higher score indicates more pain). The BARF scales has 6 faces with assigned scores ranging from 0 to 10 with a score difference of 2 between each face (a higher score indicates more nausea).

Time frame: First 24 postoperative hours

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Single CohortIncidence of Post-Discharge Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in Subjects Who Returned the DiaryNausea34 Participants
Single CohortIncidence of Post-Discharge Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in Subjects Who Returned the DiarySevere Nausea Score >6)15 Participants
Single CohortIncidence of Post-Discharge Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in Subjects Who Returned the DiaryAny Emesis16 Participants
Single CohortIncidence of Post-Discharge Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in Subjects Who Returned the DiarySevere Emesis (>= 3 episodes)3 Participants
Single CohortIncidence of Post-Discharge Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in Subjects Who Returned the DiaryRescue Antiemetics8 Participants
Single CohortIncidence of Post-Discharge Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in Subjects Who Returned the DiaryPost-Discharge Nausea OR Vomiting39 Participants
Single CohortIncidence of Post-Discharge Nausea, Emesis, Severe Nausea, Severe Emesis and Number Receiving Rescue Antiemetics in Subjects Who Returned the DiaryPost-Discharge Nausea AND Vomiting11 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026